Modeling and exploring human IRE1 as a strategy to design novel inhibitors: a computational approach

Loading...
Thumbnail Image

Journal Title

Journal ISSN

Volume Title

Publisher

Abstract

Inositol Requiring Enzyme 1 (IRE1) is a bifunctional serine/threonine kinase and endoribonuclease that is the major mediator of the Unfolded Protein Response (UPR) during endoplasmic reticulum (ER) stress. The association of IRE1 dysregulation with a wide range of human diseases, stimulated research towards the discovery of small organic molecules able to modulate IRE1 signalling, and to potentially be used as novel therapeutics. In this thesis we performed in silico three-dimensional (3D) molecular modeling analysis encompassing: (i) the selection of suitable protocols for docking and virtual screening in the IRE1 serine/threonine kinase and endoribonuclease domains studies, (ii) the exploration of IRE1 and PERK ligand interaction networks, (iii) the study of IRE1-ligand recognition phenomena in order to understand the mechanism of action of IRE1 small organic modulators and (iv) offers important insights relevant to hit-discovery and lead optimization of novel IRE1 modulators. Our structure-based drug design approach provides useful information for designing improved IRE1 ligands, as confirmed by one soon-to-be-filed patents on new inhibitors targeting IRE1, developed during the PhD period.

Description

Keywords

ER stress, unfolded protein response, cancer, inflammation, neurodegeneration, therapeutic targets, molecular docking, molecular dynamics

Citation

ISBN

978-91-7833-755-2 (PDF)
978-91-7833-754-5 (PRINT)

Articles

Carlesso, A.; Chintha, C.; Gorman, A. M.; Samali, A.; Eriksson, L. A. Binding Analysis of the Inositol-Requiring Enzyme 1 Kinase Domain. ACS Omega 2018, 3 (10), 13313–13322. DOI: https://pubs.acs.org/doi/10.1021/acsomega.8b01404

Carlesso, A.; Chintha, C.; Gorman, A. M.; Samali, A.; Eriksson, L. A. Merits and Pitfalls of Conventional and Covalent Docking in Identifying New Hydroxyl Aryl Aldehyde like Compounds as Human IRE1 Inhibitors. Sci. Rep. 2019, 9 (1), 3407. DOI: https://www.nature.com/articles/s41598-019-39939-z

Carlesso, A.; Eriksson, L. A. Selective Inhibition of IRE1 Signalling Mediated by MKC9989: New Insights from Molecular Docking and Molecular Dynamics Simulations. ChemistrySelect 2019, 4 (11), 3199–3203. DOI: https://doi.org/10.1002/slct.201900810

Carlesso A; Chintha C.; Gorman A. M.; Samali A.; Eriksson L. A. Effect of Kinase Inhibiting RNase Attenuator (KIRA) Compounds on the Formation of Face-to- Face Dimers of Inositol-Requiring Enzyme 1: Insights from Computational Modeling. Int J Mol Sci. 2019;20(22). DOI: https://www.mdpi.com/1422-0067/20/22/5538

Chintha, C.; Carlesso, A.; Gorman, A. M.; Samali, A.; Eriksson, L. A. Molecular modeling provides structural basis for PERK inhibitor selectivity towards RIPK1. Status: under revision

Doultsinos, D.; Carlesso, A.; Chintha, C.; Rainot , A. ; Paton, J.C.; Paton, A.W.; Samali, A.;Chevet, E.; Eriksson, L. A. Peptidomimetic-based identification of FDA approved compounds inhibiting IRE1 activity Status: Manuscript in preparation

Department

Department of Chemistry and Molecular Biology ; Institutionen för kemi och molekylärbiologi

Defence location

fredag den 31 01 2020 kl.10.00 i Waldemar Sjölander

Endorsement

Review

Supplemented By

Referenced By